BCL6 and viral infectious disease: Amet et al. (15) demonstrated that inhibition of the BCL-6, BR-C, ttk, and bab (BTB) domain function increased the expression of ISGs and suppressed HIV infection and replication in TFH cells, revealing a regulatory role of BCL-6 in inhibiting antiviral resistance factors, thereby promoting TFH susceptibility to viral infections (15).